regorafenib — integMET

Metabolite details

Identifier: FNHKPVJBJVTLMP-UHFFFAOYSA-N
InChI Key: FNHKPVJBJVTLMP-UHFFFAOYSA-N
IUPAC name: 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
Preferred name: regorafenib
INN name: regorafenib
Synonym: BAY 73-4506
ChEBI: CHEBI:68647

R-HSA-1433557 - Signaling by SCF-KIT
R-HSA-162582 - Signal Transduction
R-HSA-1643685 - Disease
R-HSA-186797 - Signaling by PDGF
R-HSA-5663202 - Diseases of signal transduction by growth factor receptors and second messengers
R-HSA-6802948 - Signaling by high-kinase activity BRAF mutants
R-HSA-6802957 - Oncogenic MAPK signaling
R-HSA-9006934 - Signaling by Receptor Tyrosine Kinases
R-HSA-9669921 - KIT mutants bind TKIs
R-HSA-9669929 - Regorafenib-resistant KIT mutants
R-HSA-9669937 - Drug resistance of KIT mutants
R-HSA-9669938 - Signaling by KIT in disease
R-HSA-9671555 - Signaling by PDGFR in disease
R-HSA-9674403 - Regorafenib-resistant PDGFR mutants
R-HSA-9674415 - Drug resistance of PDGFR mutants
R-HSA-9674428 - PDGFR mutants bind TKIs